These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 3292871)
41. Inhaled prostacyclin and platelet function after cardiac surgery and cardiopulmonary bypass. Haraldsson A; Kieler-Jensen N; Wadenvik H; Ricksten SE Intensive Care Med; 2000 Feb; 26(2):188-94. PubMed ID: 10784307 [TBL] [Abstract][Full Text] [Related]
42. Effect of beraprost sodium on peripheral circulation insufficiency in rats and rabbits. Murai T; Muraoka K; Saga K; Sakai A; Sato N; Amemiya K; Yajima M; Murata T; Umetsu T; Nishio S Arzneimittelforschung; 1989 Aug; 39(8):856-9. PubMed ID: 2510741 [TBL] [Abstract][Full Text] [Related]
43. The effect of prostacyclin (PGT2) on platelet behaviour. Thrombus formation in vivo and bleeding time. Ubatuba FB; Moncada S; Vane JR Thromb Haemost; 1979 Apr; 41(2):425-35. PubMed ID: 382434 [TBL] [Abstract][Full Text] [Related]
44. Thrombolytic and Antiplatelet Effects of a Novel Plasminogen Activator from the Venom of Gloydius Brevicaudus Viper. Zhang Z; Lin L; Zhang J; Zhang Q; Zhao N; Wu L; Chen J; Wu Z; Wu G; Lin J; Chen Y; Xu Y J Atheroscler Thromb; 2015; 22(10):1080-90. PubMed ID: 26004931 [TBL] [Abstract][Full Text] [Related]
45. [Thrombus models and mechanisms of action of anti-platelet drugs]. Katori M Nihon Yakurigaku Zasshi; 1992 Sep; 100(3):271-7. PubMed ID: 1398337 [TBL] [Abstract][Full Text] [Related]
46. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors. Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350 [TBL] [Abstract][Full Text] [Related]
47. Experimental study of argon laser-induced microthrombosis during PGI2 infusion. Boncinelli S; Nerucci P; Marsili M; Lorenzi P; Fenati E; Di Stefano LC; Biagiotti S; Giovannoni L Eur Surg Res; 1987; 19(3):171-7. PubMed ID: 3301363 [TBL] [Abstract][Full Text] [Related]
48. Pharmacological profile of a novel carbacyclin derivative with high metabolic stability and oral activity in the rat. Stürzebecher S; Haberey M; Müller B; Schillinger E; Schröder G; Skuballa W; Stock G; Vorbrüggen H; Witt W Prostaglandins; 1986 Jan; 31(1):95-109. PubMed ID: 3513260 [TBL] [Abstract][Full Text] [Related]
49. Ex vivo anti-platelet effects of isocarbacyclin methyl ester incorporated in lipid microspheres in rabbits. Inoue K; Aoki Y; Hayashi M; Kitahara S; Tanabe H; Kiyoki M; Araki H Arzneimittelforschung; 1995 Sep; 45(9):980-4. PubMed ID: 7488317 [TBL] [Abstract][Full Text] [Related]
50. Inhibitory effect of OP-41483.alpha-CD, a prostacyclin analog, on peripheral vascular lesion models in rats. Wakitani K; Takakuwa T; Sugioka M; Fujitani B; Aishita H Jpn J Pharmacol; 1992 May; 59(1):57-63. PubMed ID: 1507658 [TBL] [Abstract][Full Text] [Related]
51. Diminished thrombus formation and alleviation of myocardial infarction and reperfusion injury through antibody- or small-molecule-mediated inhibition of selectin-dependent platelet functions. Oostingh GJ; Pozgajova M; Ludwig RJ; Krahn T; Boehncke WH; Nieswandt B; Schön MP Haematologica; 2007 Apr; 92(4):502-12. PubMed ID: 17488661 [TBL] [Abstract][Full Text] [Related]
52. The effect of dextran on microvascular thrombosis in an experimental rabbit model. Rothkopf DM; Chu B; Bern S; May JW Plast Reconstr Surg; 1993 Sep; 92(3):511-5. PubMed ID: 7688131 [TBL] [Abstract][Full Text] [Related]
53. Double-blind, placebo-controlled study of intravenous prostacyclin on hemodynamics in severe Raynaud's phenomenon: the acute vasodilatory effect is not sustained. Kingma K; Wollersheim H; Thien T J Cardiovasc Pharmacol; 1995 Sep; 26(3):388-93. PubMed ID: 8583779 [TBL] [Abstract][Full Text] [Related]
54. Platelet inhibitory and haemodynamic effects of a new stable PGI2 analogue, cicaprost (ZK 96480), in different animal species and in man. Stürzebecher S; Hildebrand M; Schöbel C; Seifert W; Staks T Biomed Biochim Acta; 1988; 47(10-11):S45-7. PubMed ID: 3073769 [No Abstract] [Full Text] [Related]
55. Experimental cerebral ischemia produced by extracranial vascular injury: protection with indomethacin and prostacyclin. Dougherty JH; Levy DE; Rawlinson DG; Ruff R; Weksler BB; Plum F Neurology; 1982 Sep; 32(9):970-4. PubMed ID: 7050766 [TBL] [Abstract][Full Text] [Related]
56. In vivo measurement of the disaggregatory action of prostacyclin. A methodological study. Hermán F; Hadházy P; Magyar K Thromb Res; 1986 Dec; 44(5):575-85. PubMed ID: 3544328 [TBL] [Abstract][Full Text] [Related]
57. Occlusive thrombosis in the femoral artery of the rabbit: a pharmacological model for evaluating antiplatelet and anticoagulant agents. Sugidachi A; Asai F; Tani Y; Hosokawa T; Koike H Blood Coagul Fibrinolysis; 1996 Jan; 7(1):57-64. PubMed ID: 8845464 [TBL] [Abstract][Full Text] [Related]
58. The effects of prostacyclin (PGI2) on endotoxin shock and endotoxin-induced platelet aggregation in dogs. Fletcher JR; Ramwell PW Circ Shock; 1980; 7(3):299-308. PubMed ID: 7004660 [TBL] [Abstract][Full Text] [Related]
59. The cardiovascular and platelet actions of 9 beta-methyl carbacyclin (ciprostene), a chemically stable analogue of prostacyclin, in the dog and monkey. Allan G; Follenfant MJ; Lidbury P; Oliver PL; Whittle BJ Br J Pharmacol; 1985 Jun; 85(2):547-55. PubMed ID: 3896365 [TBL] [Abstract][Full Text] [Related]
60. Antiplatelet and antithrombotic activity of SL65.0472, a mixed 5-HT1B/5-HT2A receptor antagonist. Berry CN; Lorrain J; Lochot S; Delahaye M; Lalé A; Savi P; Lechaire I; Ferrari P; Bernat A; Schaeffer P; Janiak P; Duval N; Grosset A; Herbert JM; O'Connor SE Thromb Haemost; 2001 Mar; 85(3):521-8. PubMed ID: 11307825 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]